In May 2024, Genenta Science S.p.A. shareholders approved an amendment to the company's by-laws, introducing a mechanism for increased voting rights. This change grants each ordinary share owned by the same subject for a continuous period of not less than twenty-four months a double vote.
Furthermore, an additional vote is attributed at the end of each twelve-month period following the initial twenty-four-month vesting period, up to a maximum of 10 votes per ordinary share. This enhanced voting structure applies exclusively to ordinary shares and not to American Depositary Shares (ADSs).
This strategic amendment is designed to encourage and reward long-term shareholding, potentially fostering greater stability in the company's ownership and governance. It reflects a proactive approach to aligning shareholder interests with the company's long-term development goals in the biotechnology sector.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.